26th Annual Dr. Raymond C. Grandon Lecture: Vital Directions for Health and Healthcare for the Nation
Loading...
Document Type
Presentation
Presentation Date
5-24-2018
Objectives
Learning objectives:
- Assess the current state of health and healthcare in the United States (US)
- Discuss the key directions for US healthcare reform
- Examine the strategic action priorities and essential infrastructure needs to achieve a health system that performs optimally in promoting, protecting, and restoring the health of individuals and populations
Abstract:
Health care today is marked by structural inefficiencies, unprecedented costs, and fragmented care delivery, all of which place increasing pressure and burden on individuals and families, providers, businesses, and entire communities. The consequent health shortfalls are experienced across whole populations, but disproportionately impact our most vulnerable citizens due to their complex health and social circumstances.
The United States is poised at a critical juncture in health and health care. Powerful new insights are emerging on the potential of disease and disability, but the translation of that knowledge to action will have relatively limited impact on the overall health of the population without attention to broader challenges and opportunities.
Vital Directions offers a practical framework of achievable priorities that will advance health, health care and scientific progress. The ideas presented not only directly address the issues of cost and improved outcomes, but they build on interests around which there is considerable support. These are vital directions for every American.
Recommended Citation
Dzau, MD, Victor J., "26th Annual Dr. Raymond C. Grandon Lecture: Vital Directions for Health and Healthcare for the Nation" (2018). Raymond C. Grandon Lecture. Presentation 3.https://jdc.jefferson.edu/grandon/3
Language
English
Comments
Dr. Dzau is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine. In addition, he serves as Vice Chair of the National Research Council. He is an internationally acclaimed leader and scientist whose work has improved health care in the United States and globally. Since arriving at the National Academies, Dr Dzau has led important initiatives such as the Commission on a Global Health Risk Framework for the Future; the Human Gene Editing Initiative; Vital Directions for Health and Health Care; and the NAM Grand Challenges in Healthy Longevity.
His own research laid the foundation for development of a lifesaving class of drugs, ACE inhibitors, used globally to treat high blood pressure and congestive heart failure. He pioneered gene therapy for vascular disease. He is a member of the board of directors of the Singapore Health Services, a former member of the Advisory Committees to the Director of U.S. National Institutes of Health, chaired NIH's Cardiovascular Disease Advisory Committee and is past chair of the Association of Academic Health Centers.
Dr. Dzau has previously served as Chancellor for Health Affairs and President & CEO of Duke University Health system. He has received numerous awards including the Max Delbruck Medal from Germany, the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Polzer Prize from the European Academy of Sciences & Arts, the Ellis Island Medal of Honor, and the Distinguished Scientist Award of the American Heart Association.
Presentation:1:54:59
From left to right: David B. Nash, MD, MBA; Victor J. Dzau, MD; Sharon L. Larson, PhD; Jack Ludmir, MD; Edmund Pribitkin, MD, MBA, FACS